Dual National US UK: UK R&D Credits on the US Return

A UK R&D expenditure credit is a UK corporate item, but it does not stay in the UK. For a Dual national US UK owner of a British company, the merged-scheme credit is taxable income of that company, lifts its earnings and profits, feeds tested income on Form 5471, and can quietly reduce the UK corporation tax left available to support a foreign tax credit.

This guide is about reporting and correction only. It explains how a claim already made under the merged R&D expenditure credit scheme or the enhanced R&D intensive support route is characterised on a US return, where it lands on the forms, what it does to a deemed inclusion, and how to put right returns that were filed before anybody thought about it. It does not tell you whether to claim UK relief or how to structure one.

Why does a UK R&D credit appear on a US return at all?

Because the company is transparent to nobody and opaque to everybody, and yet its owner is still a US person. A UK private limited company is a foreign corporation for US purposes. Once US shareholders — people who each hold at least 10% of vote or value — together hold more than 50%, the company is a controlled foreign corporation. A founder who holds the whole of a UK operating company clears both tests on their own.

From that moment the owner is not simply reporting dividends when they arrive. They are reporting the company's results annually on Form 5471, restating those results on US principles, and picking up a deemed inclusion of the company's current-year income whether or not a penny is distributed. Anything that changes the company's profit changes that inclusion, and an R&D expenditure credit is designed precisely to change the company's profit.

The Jungle Tax cross-border team sees this most often with founders who hold a British passport and a US one, or who were born in the States and left as children, and who have built a genuinely research-intensive UK business — software, instrumentation, materials, life sciences, fintech infrastructure. The UK claim is prepared by the company's UK advisers. The US return is prepared separately. Nobody tells the US preparer that £340,000 of expenditure credit was recognised above the operating line, and the two filings diverge for years.

Merged scheme or intensive route? The distinction drives the US answer

Since accounting periods beginning on or after 1 April 2024, the old SME and RDEC schemes have been replaced by a single merged expenditure credit, with a separate enhanced R&D intensive support (ERIS) route preserved for loss-making SMEs that meet an R&D intensity threshold. The two routes are not variations on a theme. They produce fundamentally different accounting and therefore fundamentally different US consequences.

The merged scheme delivers an expenditure credit. HMRC guidance treats it as trading income subject to corporation tax. It sits above the tax line in the accounts, it increases pre-tax profit, and it is then itself taxed. The intensive route instead delivers an additional deduction and, for a surrendered loss, a payable credit that is not taxable receipts of the trade.

That single difference — taxable expenditure credit versus non-taxable payable credit — is the fork in the road for the US return.

Feature	Merged R&D expenditure credit	Enhanced R&D intensive support (ERIS)
Who it is for	Companies of any size, from periods beginning on or after 1 April 2024	Loss-making SMEs meeting the R&D intensity condition
Headline rate	20% expenditure credit on qualifying expenditure	Additional 86% deduction; payable credit up to 14.5% of the surrenderable loss
Intensity condition	None	Qualifying R&D at or above 30% of total expenditure
UK corporation tax status	Taxable — treated as trading income	Payable credit is not taxable; the enhanced deduction reduces taxable profit
Accounting presentation	Above the line; increases operating profit and EBITDA	Below the line or as a reduction in the tax charge, depending on policy
Cap on payable amount	£20,000 plus 300% of relevant PAYE and NIC	£20,000 plus 300% of relevant PAYE and NIC
US earnings and profits effect	Increases E&P as an item of income	Generally no income pick-up; the effect runs through the reduced UK tax charge
US tested income effect	Directly increases tested income	Indirect — lower UK tax means less foreign tax to credit

Read that bottom half carefully. Under the merged scheme, Washington sees more income. Under the intensive route, Washington sees roughly the same income but less foreign tax. Both can raise the US bill. They do it by different mechanisms, and they are corrected differently when they have been missed.

What "above the line" actually means for US earnings and profits

The phrase is an accounting description, not a tax rule, but it is a useful signal. A credit recognised above the line has been recognised as income. A credit that merely reduces the corporation tax charge has not.

US earnings and profits are computed on US principles, starting from the company's own books and then adjusted. The starting point matters. If the UK statutory accounts recognise a £340,000 expenditure credit as other operating income, that £340,000 is already in the profit figure the US preparer picks up, and it belongs in E&P. There is no US provision that carves out a foreign government's research incentive from a foreign corporation's income. It is a receipt of the trade, it is taxed as such in the UK, and it increases the pool of profit that the US owner may eventually be taxed on.

Where preparers go wrong is the mirror image: they treat the credit as a tax item because the words "tax credit" appear in its name, net it against the UK corporation tax line, and report a smaller profit and a smaller foreign tax at the same time. That is the worst of both worlds — understated income and understated creditable tax — and it is the single most common error we unwind.

How the credit moves through Form 5471

Form 5471 is not one form. It is a shell with schedules, and an R&D expenditure credit touches several of them. A dual national owner filing as a Category 4 and Category 5 filer will generally see the credit appear as follows.

• Schedule C — income statement. The functional-currency income statement is restated from the UK accounts. A merged-scheme expenditure credit belongs in income here, not netted against tax. Where the UK accounts already present it above the line, the restatement is straightforward; where the company's policy nets it against the tax charge, it has to be grossed back out.
• Schedule E — income, war profits and excess profits taxes paid or accrued. This is the UK corporation tax actually paid or accrued. If the expenditure credit was set against the corporation tax liability rather than paid in cash, the tax actually borne is smaller, and Schedule E must reflect the smaller figure.
• Schedule H — current earnings and profits. The credit flows into current E&P through the income line. Any US-UK book differences (development cost capitalisation, share option deductions, pension timing) are adjusted here, but the credit itself rarely needs its own adjustment — it is already income on both sides.
• Schedule I-1 — information for the global intangible low-taxed income calculation. Tested income, tested foreign income taxes and the associated detail are reported here and carried to the shareholder's inclusion computation.
• Schedule J and Schedule P — accumulated E&P and previously taxed earnings. Because the credit increases E&P and the inclusion increases previously taxed earnings, both pools move. Getting this wrong today produces phantom taxable distributions in a later year.

The IRS overview of the form and its schedules is at About Form 5471; the shareholder-level inclusion is computed on Form 8992. HMRC's own description of the merged scheme and the intensive route — including the taxable status of the expenditure credit and the PAYE and NIC cap — is published in the gov.uk guidance on the merged R&D expenditure credit scheme.

Tested income and the 2026 rules the owner actually faces

For 2026 the regime formerly labelled GILTI is recast as net CFC tested income. The mechanics a dual national owner should have in front of them when the R&D credit is added to the picture are these:

• The deduction that softens the inclusion has been reduced from 50% to 40% of the inclusion, producing an effective corporate-rate charge of 12.6% before credits rather than the old 10.5%.
• The haircut on deemed-paid foreign taxes has narrowed, with 90% of the associated foreign tax now available rather than 80%.
• The deemed return on qualified business asset investment has been removed, so a company that previously sheltered part of its profit behind tangible assets no longer does. The whole of tested income is exposed.
• Interest and research or experimental expenses are not allocated against the inclusion for limitation purposes, and other deductions are allocated only where directly allocable.

Put the expenditure credit into that frame. A £340,000 merged-scheme credit increases tested income by roughly the gross credit, less the UK tax charged on it. Against that, the UK corporation tax on the enlarged profit is a tested foreign income tax and is creditable subject to the haircut and the limitation. For a company paying UK corporation tax at the main rate, the arithmetic usually still lands in the owner's favour — the UK cash is worth more than the US cost. But "usually" is not "always", and it is never nothing.

The outcome changes materially if the owner is not making a corporate-rate election. Without one, an individual picks up the inclusion at individual rates with no deemed-paid credit for the company's UK tax. In that posture the expenditure credit is pure additional income with no offsetting foreign tax at all — an unrelieved US charge on a British innovation subsidy. This is the fact pattern that produces the largest corrections, and it is why the interaction between the credit and the election has to be examined together rather than in sequence. Our wider treatment of the mechanics sits under cross-border tax planning.

Does the credit reduce the UK tax you can claim as a foreign tax credit?

This is where the two routes diverge most sharply, and where generalist pages tend to stop.

A foreign tax credit requires a foreign tax to have been paid or accrued. Amounts that are refunded, rebated, credited or forgiven are not creditable, and the compulsory payment principle asks whether the taxpayer exhausted reasonable means of reducing the liability. Recent regulatory tightening excluded from creditable tax amounts that could be settled by a subsidy, incentive or credit rather than by a cash payment.

Apply that to a UK claim. The merged expenditure credit is applied through a prescribed sequence: discharge of the corporation tax liability for the period first, then restriction by reference to the PAYE and NIC cap, then set-off against other liabilities, then payment of any remainder. Where the credit is absorbed in step one, the company's corporation tax liability has been discharged by the credit rather than paid in cash. That portion of the UK tax is not available to support a US foreign tax credit, because the UK never collected it.

Where the credit is paid out in cash — the typical loss-making or low-profit position — the company has both an income receipt and, separately, whatever corporation tax it actually paid. Those are two distinct items, and the cash corporation tax is creditable in the ordinary way.

The practical consequence: a preparer who reads only the UK corporation tax computation's headline liability, without looking at how that liability was discharged, will overstate creditable tax on Schedule E and on the shareholder's credit computation. Overstated foreign tax credits are not a harmless error. They understate tax, they extend exposure, and on examination they unwind across every year in the chain.

What happens when prior years were computed without the credit

Most of the work in this area is remedial. The company claimed in, say, its 2022, 2023 and 2024 periods; the US returns for those years were prepared from management accounts that had not been adjusted, or from statutory accounts the preparer read as showing a tax-line item. Three or four years of Forms 5471 now carry the wrong income, the wrong E&P and the wrong tested income, and the previously taxed earnings pools are wrong in both directions.

The sequence we work through:

• Establish the true UK position first. Obtain the filed CT600s, the corporation tax computations, the R&D claim schedules and the additional information submitted to HMRC for each period. Identify, per period, the gross credit, the amount set against corporation tax, the amount capped and carried forward, and the amount paid in cash.
• Rebuild E&P from the earliest affected year forward. E&P is cumulative. You cannot correct 2024 and leave 2022 alone; the opening balance carries the error forward and the Schedule J reconciliation will not close.
• Recompute the inclusion for each year on that year's rules. Years before 2026 use the rules then in force, including the deduction and haircut percentages of those years. Do not apply 2026 arithmetic retrospectively.
• Restate Schedule E for each year to the UK tax actually borne, distinguishing cash payments from liabilities discharged by the credit.
• Amend the individual returns. Corrected Forms 5471 and 8992 are filed with amended Forms 1040-X for each affected year, with a clear statement of what changed and why.
• Reconcile the previously taxed earnings accounts so that later distributions are not taxed twice, and so that any basis adjustments follow the corrected inclusions.

Two timing points matter. First, the ordinary refund window is limited, so a correction that reduces US tax in an early year may be outside the period for a refund even though the reporting must still be put right. Second, an incomplete or unfiled Form 5471 can hold the assessment period open for the whole return until the form is properly filed — so a missing or materially wrong 5471 is not simply a penalty exposure, it is an open year.

Where the omission is part of a broader pattern of unfiled or under-filed years, the correction may belong inside a formal compliance procedure rather than a bare amended return. That assessment turns on whether the failure was non-wilful and on what else is outstanding; we set out the routes under IRS streamlined filing, and the penalty arithmetic on unreported accounts is modelled in our FBAR penalty calculator.

Penalties, and why this is not a small-ticket error

The information-return penalty regime for Form 5471 is severe and does not depend on tax being due. A failure attracts a substantial per-form, per-year penalty, with continuation penalties running in 30-day increments after formal notice up to a further ceiling, and a potential reduction of foreign tax credits on top. A form filed with materially wrong income and E&P can be treated as substantially incomplete.

For a founder with a research-intensive company claiming a meaningful credit every year, three or four defective forms is a five-figure exposure before any tax. Reasonable cause is available, but it is evidenced, not asserted — which is another argument for correcting proactively rather than waiting.

A worked sequence

Consider a dual national who owns 100% of a UK company with qualifying R&D expenditure of £1.7m in a period beginning after 1 April 2024, claiming under the merged scheme. The gross expenditure credit at the headline rate is £340,000. The company is profitable; the credit is recognised above the line, increases pre-tax profit, and is itself subject to corporation tax. A portion is applied to discharge the corporation tax liability for the period.

On the US return: Schedule C carries the £340,000 as income. Schedule H carries it into current E&P. Schedule E carries only the corporation tax actually paid in cash, not the amount discharged by the credit. Schedule I-1 shows the enlarged tested income and the reduced tested foreign income taxes. The owner's inclusion rises on both counts — more income, less credit — and the net US cost depends heavily on whether a corporate-rate election is in place.

Now suppose the same company claimed on the same basis in the three preceding periods and none of it reached the US return. The correction is not three amended forms; it is a rebuilt four-year E&P history, four recomputed inclusions on four years of rules, four restated foreign tax positions, and a reconciled previously taxed earnings account — then the amended returns. That is the actual scope of work, and it is why the fee conversation should start before the filing deadline rather than after a notice.

What your US preparer needs from the UK side

• Statutory accounts and the audit or accountants' report for every affected period, with the accounting policy note for the credit.
• The filed CT600 and the full corporation tax computation, showing how the credit was applied step by step.
• The R&D claim schedule and the additional information form submitted to HMRC, including the qualifying expenditure categories.
• Bank evidence of any cash credit received and of corporation tax actually paid, with dates.
• Details of any capped amount carried forward, and of any period where the claim was amended or enquired into.
• The share register, so that ownership percentages and any changes in the year are documented for the filing categories.

If the same individual also holds UK pensions, ISAs or investment accounts that have not been reported, those sit in the same remediation and should be scoped together rather than sequentially. Our work for founders and substantial shareholders sits under high net worth and business and corporate tax, and the wider library is at our guides.

Common mistakes we correct

• Netting the expenditure credit against the corporation tax charge on Schedule C, understating both income and creditable tax.
• Treating an ERIS payable credit as taxable income because it was assumed to work like the merged scheme.
• Claiming the full headline corporation tax liability on Schedule E when part of it was discharged by the credit rather than paid.
• Correcting the most recent year only, leaving the opening E&P balance wrong and the Schedule J reconciliation unclosed.
• Applying current-year inclusion percentages to earlier years.
• Failing to update previously taxed earnings, producing a taxable distribution years later on income already taxed.
• Assuming that because the UK incentive is a "credit", it must be a credit for US purposes too. It is income.

Speak to us in confidence

If your UK company has claimed under the merged expenditure credit scheme or the intensive route, and you are not certain the receipt has been characterised correctly on your Forms 5471 and 8992 — or you know it has not — the position is correctable, and it is considerably cheaper to correct before the IRS raises it. We prepare and remediate US and UK returns for dual nationals and founders with British operating companies, and we work only on reporting and compliance. To review your filed years and scope a correction, contact our cross-border team for a confidential consultation.